David A. Siegel Global Cord Blood Corp Transaction History

Two Sigma Advisers, LP

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.2 - $3.98 $220 - $398	-100 Reduced 0.87%	11,400 $34,000
Q1 2022 May 16, 2022	SELL	$3.74 - $4.55 $7,106 - $8,645	-1,900 Reduced 14.18%	11,500 $44,000
Q4 2021 Feb 14, 2022	BUY	$3.9 - $4.75 $3,900 - $4,750	1,000 Added 8.06%	13,400 $56,000
Q3 2021 Nov 15, 2021	BUY	$4.57 - $5.39 $56,668 - $66,836	12,400 New	12,400 $58,000
Q3 2020 Nov 16, 2020	SELL	$2.99 - $3.89 $138,670 - $180,410	-46,378 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$2.56 - $3.37 $512 - $674	-200 Reduced 0.43%	46,378 $144,000
Q1 2020 May 15, 2020	SELL	$2.98 - $5.22 $2,086 - $3,654	-700 Reduced 1.48%	46,578 $148,000
Q4 2019 Feb 14, 2020	SELL	$4.37 - $5.67 $27,968 - $36,288	-6,400 Reduced 11.92%	47,278 $236,000
Q3 2019 Nov 14, 2019	SELL	$4.2 - $5.87 $5,040 - $7,044	-1,200 Reduced 2.19%	53,678 $260,000
Q2 2019 Aug 14, 2019	SELL	$5.35 - $7.55 $110,793 - $156,352	-20,709 Reduced 27.4%	54,878 $317,000
Q1 2019 May 15, 2019	BUY	$5.81 - $7.6 $53,504 - $69,988	9,209 Added 13.87%	75,587 $531,000
Q4 2018 Feb 14, 2019	SELL	$5.71 - $7.01 $89,127 - $109,419	-15,609 Reduced 19.04%	66,378 $428,000
Q3 2018 Nov 14, 2018	BUY	$6.37 - $9.29 $85,912 - $125,294	13,487 Added 19.69%	81,987 $573,000
Q2 2018 Aug 14, 2018	SELL	$9.07 - $10.11 $406,336 - $452,928	-44,800 Reduced 39.54%	68,500 $650,000
Q1 2018 May 15, 2018	BUY	$8.71 - $11.87 $986,843 - $1.34 Million	113,300 New	113,300 $1.16 Million

44.8K

Ticker CO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 133,915,000
Description
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matchin...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.